Protocol Ledger

NCT04389086 · Phase III · RECRUITING

Induction Chemotherapy for Locally Recurrent Rectal Cancer

Interventional Phase III clinical trial protocol NCT04389086 sponsored by Catharina Ziekenhuis Eindhoven in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-11-13 Enrollment: 364 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04389086
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)364 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04389086
Protocol FieldVerified Registry Value
NCT IdentifierNCT04389086
Consolidated Lead SponsorCatharina Ziekenhuis Eindhoven
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment364 participants (ESTIMATED)
Registered Start Date2020-11-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04389086
Hospital Research SiteLocationSite Profile
UZ GentGhent, BelgiumOpen Hospital Dossier ->
Amsterdam UMCAmsterdam, NetherlandsOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI